Diabetes

Policies across federal programs vary, with those serving active military and veterans having fewer barriers than Medicare.

The researchers say more research is needed to positively link the gut bacteria changes to health outcomes.

Results from the first 70 days of the Virta Clinic trial suggest the historic dietary approach to management of type 2 diabetes has been all wrong.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

A new study published in the New England Journal of Medicine finds that the incidence of diabetes is trending upwards among youth, particularly for racial and ethnic minorities.

The news comes the week of the 10th anniversary of Amy Tenderich's famous "Open Letter to Steve Jobs," which called on the tech giant to bring innnovation and better design to diabetes products.

Full recognition is key as the provider of the Diabetes Prevention Program awaits rules for Medicare reimbursement. CMS will offer the program to Medicare beneficiaries in 2018.

The lead study author said the findings are important to help medical professionals identify teens most at risk of developing diabetes or cardiovascular disease as adults.

The small study found that elementary-school age children spent less time out of range while using the artificial pancreas system. The first product meeting the defintion of "artificial pancreas" will be available for adults from Medtronic this summer.

Faced with an overwhelming amount of healthcare settings and information, patients with diabetes could find that digital health tools are a powerful resource for managing their illness, according to Heather Zacker, MS, senior director of Care Alliances of Joslin Innovation at Joslin Diabetes Center.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top stories in managed care included the president's pick to lead the FDA testified before a Senate committee; Mylan recalls EpiPen batches and faces a class action lawsuit; and a study ties being a night owl to increased depression in patients with diabetes.

Research presented this week at the 99th annual meeting of the Endocrine Society suggested that people with type 2 diabetes who worked overnight shifts tend to have poorer control over their blood sugar levels than those who worked during the day or were unemployed.

New payment models in Medicare and beyond recognize the connection between mental health and conditions like diabetes and obesity.

The new study shows that looking at a person's body mass index over an extended period gives a fuller picture of the relationship between excess weight and mortality.

More studies are recognizing the role of sleep in overall health, along with diet and exercise.

Children need support from their families to fight obesity, as they lack the tools to change their diet and exercise patterns alone, according to Fatima Cody Stanford, MD, MPH, MPA, FAAP, FTOS, of Harvard Medical School and Massachusetts General Hospital. Getting obesity under control in childhood is key to reducing the risk of negative health outcomes later in life.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

With new technologies that allow insulin to be delivered much more easily and at a targeted speed, diabetes treatment is less likely to interfere with patients’ lives, explained Yehuda Handelsman, MD, FACP, FACE, FNLA, medical director and principal investigator at the Metabolic Institute of America.

This week, the top managed care news included new radiology guidelines for early-stage breast cancer; 4 continuing healthcare challenges for President Donald Trump; and Medicare coverage for Dexcom's continuous glucose monitor.

A new study published in Annals of Internal Medicine has observed encouraging results from a program that implemented a virtual glucose management system for hospital inpatients.

While rare, diabetic ketoacidosis occurs overwhelmingly in patients taking SGLT2 inhibitors with type 2 diabetes, according to the analysis from 3 North Carolina medical schools.

Liz Zhou, MD, director of evidence-based medicine at Sanofi Medical Affairs outlined the purpose of a study on real-world results of comparing basal insulin dose changes in type 2 diabetes patients using Lantus who either stay on Lantus or switch to Toujeo.

Dexcom's G5 Mobile is the only continuous glucose monitoring system that meets Medicare criteria for coverage. However, details of the coverage rules released this week state that people with diabetes who want coverage cannot use the system with a smartphone app.

Other studies have examined the link between snoring and diabetes. The lack of oxygen in snoring leads to increased insulin resistance, researchers believe.